• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Insmed Incorporated (INSM)

    -NasdaqGS
    12.33 Down 0.45(3.52%) Feb 8, 4:00PM EST
    |After Hours : 12.40 Up 0.07 (0.57%) Feb 8, 6:23PM EST
    Prev Close:12.78
    Open:12.46
    Bid:N/A
    Ask:12.60 x 1000
    1y Target Est:27.14
    Beta:1.01336
    Earnings Date:Feb 25 - Feb 29 (Est.)
    Day's Range:12.07 - 13.04
    52wk Range:12.07 - 28.66
    Volume:743,724
    Avg Vol (3m):499,479
    Market Cap:762.04M
    P/E (ttm):N/A
    EPS (ttm):-1.89
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INSMDown 3.52%762.04M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.00
    Quarterly EPS Est (Dec-15) :-0.49
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers an anti-in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback